APA-viite

Johnson, J. K., Liranso, T., Saylor, K., Tulloch, G., Adewole, T., Schwabe, S., . . . Newcorn, J. H. (2019). A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD. J Atten Disord.

Chicago-tyylinen lähdeviittaus

Johnson, Janet K., Tesfaye Liranso, Keith Saylor, Gabriela Tulloch, Toyin Adewole, Stefan Schwabe, Azmi Nasser, Robert L. Findling, ja Jeffrey H. Newcorn. "A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD." J Atten Disord 2019.

MLA-viite

Johnson, Janet K., et al. "A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD." J Atten Disord 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.